Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -24.59%92.2B | -17.51%455.38B | -18.79%335.09B | -20.52%237.53B | -18.46%122.27B | -12.91%552.02B | -11.71%412.62B | -10.65%298.84B | 3.81%149.95B | 6.95%633.87B |
| Operating revenue | -24.59%92.2B | -17.51%455.38B | -18.79%335.09B | -20.52%237.53B | -18.46%122.27B | -12.91%552.02B | -11.71%412.62B | -10.65%298.84B | 3.81%149.95B | 6.95%633.87B |
| Other operating revenue | ---- | -1.71%1.34B | ---- | 5.13%703.06M | ---- | -3.39%1.36B | ---- | 3.22%668.77M | ---- | 35.42%1.41B |
| Total operating cost | -24.06%90.11B | -17.16%441.59B | -19.10%323.54B | -20.78%228.57B | -18.15%118.66B | -12.70%533.08B | -11.07%399.94B | -10.02%288.51B | 5.04%144.97B | 6.90%610.63B |
| Operating cost | -24.40%84.27B | -17.87%409.45B | -19.64%301.6B | -21.43%213.56B | -19.04%111.47B | -12.91%498.54B | -11.53%375.3B | -10.44%271.8B | 5.25%137.67B | 6.90%572.46B |
| Operating tax surcharges | -17.06%296M | 24.43%2.68B | -16.78%1.23B | -3.77%877.16M | -3.21%356.9M | 12.23%2.16B | 8.05%1.47B | -8.40%911.5M | -21.21%368.74M | 2.69%1.92B |
| Operating expense | -14.70%562.42M | -1.28%3.02B | -7.98%1.86B | -5.94%1.3B | -5.75%659.37M | -3.34%3.06B | 0.42%2.02B | -0.43%1.39B | 6.35%699.61M | 9.93%3.17B |
| Administration expense | -11.90%2.67B | -2.94%11.48B | -5.43%7.79B | -6.58%5.33B | -4.93%3.03B | -4.29%11.83B | 1.85%8.23B | 5.21%5.71B | 3.76%3.19B | 9.64%12.36B |
| Financial expense | 33.49%459.29M | -8.30%989.22M | 9.63%1.1B | 18.28%753.8M | 54.42%344.07M | 9.06%1.08B | 94.83%1.01B | 156.36%637.3M | 16.02%222.82M | 5.13%989.12M |
| -Interest expense (Financial expense) | 22.96%665.81M | 7.71%3.65B | 12.99%2.16B | 9.89%1.44B | 30.99%541.46M | 28.35%3.39B | 16.34%1.91B | -5.42%1.31B | 47.40%413.37M | 0.39%2.64B |
| -Interest Income (Financial expense) | -74.21%-518.98M | -27.13%-3.45B | -1.01%-1.47B | 3.75%-937.17M | 6.02%-297.9M | -35.68%-2.72B | -47.18%-1.46B | -0.48%-973.65M | 11.44%-316.97M | 17.41%-2B |
| Research and development | -33.84%1.85B | -14.89%13.96B | -16.29%9.96B | -16.50%6.73B | -0.63%2.8B | -16.85%16.41B | -12.09%11.9B | -11.25%8.07B | 0.11%2.82B | 5.33%19.73B |
| Credit Impairment Loss | 241.13%414.84M | -14.19%-8.21B | 13.54%-1.97B | 31.38%-1.91B | 30.75%-293.95M | -20.01%-7.19B | 7.00%-2.28B | -51.64%-2.78B | 20.23%-424.45M | -66.42%-5.99B |
| Asset Impairment Loss | 61.13%-244.58M | -665.06%-19.44B | -3.31%-2.08B | 18.62%-1.7B | -28.06%-629.16M | 14.01%-2.54B | -29.09%-2.02B | -67.03%-2.09B | -29.45%-491.31M | -117.32%-2.95B |
| Other net revenue | 120.55%209.35M | 12.84%-8.6B | -18.36%-4.45B | 19.82%-3.68B | 7.58%-1.02B | -3.52%-9.86B | 23.85%-3.76B | -18.12%-4.59B | 3.24%-1.1B | -57.07%-9.53B |
| Fair value change income | 143.72%25.38M | 91.86%-30.72M | 69.32%-22.73M | 79.37%-44.68M | 68.43%-58.05M | -20.04%-377.21M | 83.85%-74.08M | 34.04%-216.6M | -5,553.63%-183.86M | 1.12%-314.22M |
| Invest income | 62.31%-49.78M | 1,442.85%18.19B | -21.27%-869.6M | 25.82%-445.76M | 38.60%-132.06M | 8.93%-1.35B | 10.98%-717.08M | 14.39%-600.91M | 31.72%-215.08M | 2.35%-1.49B |
| -Including: Investment income associates | -123.04%-39.99M | -142.84%-58.84M | -383.02%-166.87M | -368.99%-52.24M | -234.54%-17.93M | -72.87%137.33M | -56.92%58.96M | -81.80%19.42M | 41.81%13.33M | 184.81%506.15M |
| Asset deal income | -80.71%2.01M | -65.36%364.63M | -80.85%192.11M | -78.92%178.67M | -92.96%10.4M | 58.76%1.05B | 1,856.49%1B | 2,395.55%847.46M | 832.47%147.71M | 118.58%663.08M |
| Other revenue | -26.92%61.48M | -3.05%533.45M | -5.97%308.33M | -3.82%239.66M | 29.99%84.13M | -1.76%550.23M | 12.05%327.9M | 27.64%249.16M | -13.55%64.72M | 29.29%560.09M |
| Operating profit | -11.38%2.3B | -42.81%5.19B | -20.31%7.11B | -7.94%5.29B | -33.05%2.59B | -33.78%9.08B | -29.51%8.92B | -42.29%5.74B | -26.89%3.88B | -10.85%13.72B |
| Add:Non operating Income | 141.48%95.01M | -11.62%400.9M | -31.33%164.94M | -10.42%127.46M | -40.07%39.34M | 57.06%453.58M | 28.57%240.2M | 104.07%142.29M | 30.88%65.65M | -10.61%288.79M |
| Less:Non operating expense | -8.47%24.56M | 107.98%586.39M | 3.46%253.4M | -33.59%136.65M | -48.90%26.83M | 17.55%281.95M | 55.26%244.92M | 63.41%205.75M | 155.35%52.51M | -24.05%239.85M |
| Total profit | -9.10%2.37B | -45.87%5.01B | -21.26%7.02B | -7.08%5.28B | -32.95%2.61B | -32.77%9.25B | -29.71%8.92B | -42.61%5.68B | -27.05%3.89B | -10.57%13.76B |
| Less:Income tax cost | -25.52%396.39M | 84.21%2.49B | 34.12%1.63B | 23.01%1.21B | -28.47%532.18M | -42.76%1.35B | -44.30%1.22B | -19.60%980.52M | -21.02%743.95M | -4.14%2.36B |
| Net profit | -4.90%1.97B | -68.09%2.52B | -30.01%5.39B | -13.35%4.07B | -34.01%2.08B | -30.70%7.9B | -26.67%7.7B | -45.84%4.7B | -28.34%3.14B | -11.80%11.41B |
| Net profit from continuing operation | -22.37%1.97B | -27.23%7.71B | -30.01%5.39B | -13.35%4.07B | -19.16%2.54B | -7.09%10.6B | -26.67%7.7B | -45.84%4.7B | -28.34%3.14B | -11.80%11.41B |
| Net income from discontinuing operating | ---- | -92.73%-5.19B | ---- | ---- | ---467.03M | ---2.69B | ---- | ---- | ---- | ---- |
| Less:Minority Profit | -27.16%340.89M | 3.62%1.2B | 63.30%1.42B | 76.75%973.71M | 0.39%468M | -57.66%1.16B | -62.49%868.48M | -62.30%550.89M | -54.16%466.2M | 3.02%2.74B |
| Net profit of parent company owners | 1.59%1.63B | -80.41%1.32B | -41.88%3.97B | -25.31%3.1B | -40.00%1.61B | -22.20%6.75B | -16.53%6.83B | -42.50%4.15B | -20.56%2.68B | -15.63%8.67B |
| Earning per share | ||||||||||
| Basic earning per share | 0.00%0.08 | -99.17%0.002 | -45.83%0.13 | -18.18%0.09 | -33.33%0.08 | -27.27%0.24 | -22.58%0.24 | -57.69%0.11 | -20.00%0.12 | -26.67%0.33 |
| Diluted earning per share | 0.00%0.08 | -99.17%0.002 | -45.83%0.13 | -18.18%0.09 | -33.33%0.08 | -27.27%0.24 | -22.58%0.24 | -57.69%0.11 | -20.00%0.12 | -26.67%0.33 |
| Other composite income | 5.83%63.91M | 37.71%-223.91M | 54.86%-133.52M | 89.89%-26.31M | -13.62%60.39M | -640.08%-359.48M | -294.25%-295.81M | -201.01%-260.2M | 187.64%69.9M | -95.57%66.56M |
| Other composite income of parent company owners | 2.78%69.41M | 48.06%-189.51M | 60.77%-105.7M | 94.94%-13.67M | 8.74%67.53M | -1,472.86%-364.85M | -385.52%-269.41M | -255.28%-270.5M | 205.81%62.1M | -98.09%26.58M |
| Other composite income of minority owners | 23.05%-5.5M | -740.45%-34.41M | -5.40%-27.82M | -222.78%-12.64M | -191.60%-7.15M | -86.56%5.37M | -145.57%-26.39M | -87.66%10.3M | 137.02%7.8M | -64.67%39.98M |
| Total composite income | -4.59%2.04B | -69.54%2.3B | -29.02%5.25B | -8.87%4.05B | -33.57%2.14B | -34.24%7.54B | -30.49%7.4B | -50.31%4.44B | -25.40%3.21B | -20.52%11.47B |
| Total composite income of parent company owners | 1.64%1.7B | -82.26%1.13B | -41.10%3.86B | -20.46%3.09B | -38.90%1.67B | -26.63%6.38B | -20.74%6.56B | -47.52%3.88B | -17.28%2.74B | -25.45%8.7B |
| Total composite income of minority owners | -27.22%335.39M | 0.18%1.17B | 65.11%1.39B | 71.26%961.07M | -2.77%460.85M | -58.07%1.16B | -64.52%842.09M | -63.67%561.19M | -52.41%474M | 0.25%2.78B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Accounting Firm (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.